Wells Fargo & Company »

Briacell Therapeutics Corp shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Briacell Therapeutics Corp (BCTX) shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Briacell Therapeutics Corp

Tip: Access up to 7 years of quarterly data

All positions including Briacell Therapeutics Corp held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Briacell Therapeutics Corp by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2024-09-30 $360 290 1.24

More positions owned by Wells Fargo & Company

Microsoft Corporation (MSFT)
Apple Put Option (AAPL)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Ishares Tr Russell 2000 Etf (IWM)
Ishares Tr Core S&p500 Etf (IVV)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Core S&p Ttl Stk (ITOT)
NVIDIA Corporation (NVDA)
Vanguard Index Fds Mid Cap Etf (VO)
Amazon (AMZN)
JPMorgan Chase & Co. Put Option (JPM)
Ishares Tr Core Us Aggbd Et (AGG)
Ishares Tr Core Msci Eafe (IEFA)
UnitedHealth (UNH)
Broadcom (AVGO)

View all positions for Wells Fargo & Company

Top funds holding Briacell Therapeutics Corp

Redmond Asset Management
Vontobel Holding
Hrt Financial
Citadel Advisors
Onyx Bridge Wealth Group
Group One Trading
Summit Trail Advisors
LPL Financial
Cambridge Investment Research Advisors
HighTower Advisors
Concord Wealth Partners
Susquehanna International
National Bank Of Canada /fi/
Royal Bank of Canada
TD Waterhouse Canada

View all funds holding Briacell Therapeutics Corp